In the rapidly evolving field of treating cardiac arrhythmias, the importance of direct management of patients with implantable cardiac devices is growing. The devices have become increasingly complex, and understanding their algorithms and growing programming options is essential for physicians who implant and manage them. Written by experts and world authorities in the field, Pacemakers and Implantable Cardioverter Defibrillators: An Expert's Manual provides electrophysiologists, fellows in training, nurses, and cardiovascular technicians involved in day-to-day management of device patients with detailed information about the many device algorithms and interactions. *Heavily illustrated with over 300 figures and tables *Uniquely meets the day-to-day needs of all direct management professionals *Focuses in detail on algorithms *Describes device interactions, addressing every major manufacturer *Provides in-depth insight into pacing, including biventricular pacing *Discusses arrhythmia detection and device classification, testing, and therapy

Advancements in the treatment and prevention of Atrial Fibrillation are presented in this important new book. Atrial Fibrillation affects approximately 2.5 million individuals in the United States and is projected to affect 15 million individuals by 2050. In Atrial Fibrillation: From Bench to Bedside, the reader is provided with the latest information that is critically important in the daily care and for the potential cure of patients with Atrial Fibrillation. Each chapter deals with a different aspect of Atrial Fibrillation and was authored by internationally recognized experts in the evolving field of cardiac electrophysiology. This book is a single source that provides a multi-perspective look at and approach to Atrial Fibrillation. Because Atrial Fibrillation is so prevalent and affects all areas of medicine, the information in this book will be useful to cardiologists, cardiac surgeons, researchers, and all those in the medical field.

Implantable defibrillators as originally conceived by Michel Mirowski were limited to the detection and automatic termination of ventricular fibrillation. In the original "AID" device, the detection algoritlun sought to distinguish sinus rhytlun from ventricular fibrillation by identifying the "more sinusoidal waveform of ventricular fibrillation. " The therapeutic intervention was elicited only once deadly polymorphic rhythms had developed. It was rapidly learned, however, that ventricular fibrillation is usually preceded by ventricular tachycardia. Mirowski recognized the pivotal importance of developing algoritllms based on heart rate. Ventricular tachycardia detection allowed the successful development of interventions for the termination of ventricular tachyarrhythmias before they degenerated into ventricular fibrillation. Current device therapy no longer confines itself to tlle termination of chaotic rhythms but seeks to prevent them. Diagnostic algorithms moved upward along the chain of events leading to catastrophic rhytlulls. Rate smoothing algorithms were developed to prevent postextrasystolic pauses from triggering ventricular and atrial tachyarrhytlmlias. Beyond the renaissance of ectopy-centered strategies, long-term prevention received increasing attention. Multisite pacing therapies provided by "Arrhythmia Management Devices" were designed to reduce the "arrhytlunia burden" and optimize the synergy of cardiac contraction and relaxation. Clinical evidence now suggests that atrial fibrillation prevention by pacing is feasible and tllat biventricular pacing may be of benefit in selected patients with heart failure. However, these applications of device therapy that generally require ventricular defibrillation backup remain investigational and were not considered in this book.

The second edition of this bestseller provides a practical, user-friendly manual guiding the theory and practice of cardiac electrophysiology. The handbook provides the specialist in training with a thorough grounding procedures, and clinical findings for clinicians. It provides a review of the main kinds of arrhythmia with illustrations of typical ECG findings supported where appropriate by correlative imaging. It also details the principal diagnostic and therapeutic procedures include implantation of pacemakers, resynchronization therapy, and ablation techniques. Key Features Provides concise, user friendly guide to the equipment, procedures and clinical findings with which EPs need to be familiar Delivers alternatives resource to the flagship titles available in this field - idea for those beginning training or seeking an update Presents extensively updated material to enhance comprehension Includes new treatments and devices for electrophysiologists trained to perform interventional cardiac electrophysiology studies (EPS) as well as surgical device implantations

Focusing on anatomy and procedural strategy for atrial fibrillation and ventricular tachycardia, this atlas uses pictures and schematic diagrams to show how to use intracardiac echo (ICE) to assess anatomy, guide ablation, and prevent complications during interventional procedures, pulmonary vein stenosis, and embolic events. The authors review the state of the art and background support in the use of ICE in interventional electrophysiology procedures and the anatomy of both the atrial and ventricular chambers. They discuss innovative indications in the EP laboratory, future technologies such as 3-D echocardiography, and the integration of ICE with other types of imaging technology.

An Atlas of Radioscopic Catheter Placement is unique, and has been conceived as a handy reference guide for students, interventional cardiologists, nurses and electrophysiology technicians. It includes plenty of schemes and X-ray images, and every EP correct catheter positioning is explained step by step through detailed descriptions of the necessary manoeuvres, including some "trucks" brought about by the experience.

Implantable defibrillators as originally conceived by Michel Mirowski were limited to the detection and automatic termination of ventricular fibrillation. In the original "AID" device, the detection algoritlun sought to distinguish sinus rhytlun from ventricular fibrillation by identifying the "more sinusoidal waveform of ventricular fibrillation. " The therapeutic intervention was elicited only once deadly polymorphic rhythms had developed. It was rapidly learned, however, that ventricular fibrillation is usually preceded by ventricular tachycardia. Mirowski recognized the pivotal importance of developing algoritllms based on heart rate. Ventricular tachycardia detection allowed the successful development of interventions for the termination of ventricular tachyarrhythmias before they degenerated into ventricular fibrillation. Current device therapy no longer confines itself to tlle termination of chaotic rhythms but seeks to prevent them. Diagnostic algorithms moved upward along the chain of events leading to catastrophic rhytlulls. Rate smoothing algorithms were developed to prevent postextrasystolic pauses from triggering ventricular and atrial tachyarrhytlmlias. Beyond the renaissance of ectopy-centered strategies, long-term prevention received increasing attention. Multisite pacing therapies provided by "Arrhythmia Management Devices" were designed to reduce the "arrhytlunia burden" and optimize the synergy of cardiac contraction and relaxation. Clinical evidence now suggests that atrial fibrillation prevention by pacing is feasible and tllat biventricular pacing may be of benefit in selected patients with heart failure. However, these applications of device therapy that generally require ventricular defibrillation backup remain investigational and were not considered in this book.

In this issue of Cardiac Electrophysiology Clinics, guest editors Drs. Domenico G. Della Rocca, Giovanni B. Forleo, and Andrea Natale bring their considerable expertise to the topic of Arrhythmic and Vascular Complications of Coronavirus Disease 2019 (COVID-19). Top experts in the field cover key topics such as prevalence and clinical implications of COVID-19 myocarditis; electrocardiographic and echocardiographic features of COVID-19 patients; imaging findings of COVID-19-related cardiovascular complications; the role of digital health during COVID-19 pandemic; and more. Contains 14 relevant, practice-oriented topics including prevalence, management, and outcomes of supraventricular arrhythmias in COVID-19 patients; prevalence, management, and outcomes of ventricular arrhythmias in COVID-19 patients; COVID-19 associated endothelial dysfunction and microvascular injury; COVID-19, acute myocardial injury, and infarction; and more. Provides in-depth clinical reviews on arrhythmic and vascular complications of COVID-19, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting approximately 2.3 million people in the US. One of the most serious side effects of AF is embolic stroke. Technology developed in the last 10 years has made AF treatable and potentially curable. This issue discusses many of the clinical issues in the management of AF, including cardioversion, anticoagulation, and ablation. Also included are current guidelines for treatment and a view of the future.

This important new book presents advancements in the treatment and prevention of Atrial Fibrillation (AF). The reader is provided with the latest information that is critically important in the daily care and for the potential cure of patients with AF. Each chapter deals with a different aspect of AF and each chapter is authored by internationally recognized experts in the evolving field of cardiac electrophysiology. This book is a single source that provides a multi-perspective look at and approach to AF. Because AF is so prevalent and affects all areas of medicine, the information in this book will be useful to all those in the medical field.

This issue of Cardiac Electrophysiology Clinics devoted to syncope a disorder that is associated with increased mortality. Internationally recognized experts discuss the many causes of syncope, helping the clinician to distinguish life-threatening etiologies from benign ones.

Debates and controversies about how to treat difficult problems or conditions abound in cardiac electrophysiology.? This issue attempts to bring together a variety of controversial subjects and to present differing views on how to resolve these questions so clinicians will have a handy guide to the most current thinking about these difficult subjects.

Cardiac electrophysiologists face many challenging situations in which there is no clear-cut answer about the best way to handle a particular clinical problem. This issue brings together articles on many such situations, presents arguments on both sides, and lets the reader conclude which is the best way to manage a particular patient.? Among the controversial and debatable topics included are how to handle device recalls, optimal timing for assessment of ICD efficacy, extraction o f broken leads, and anticoagulation therapy in device patients.

In the United States, 50-60 individuals suffer a cardiac arrest each hour, amounting to approximately 250,000 deaths every year. In the first five minutes of a cardiac arrest, ventricular tachycardia (VT) and ventricular fibrillation are the most frequent cardiac arrhythmias encountered. Despite emergency medical response systems, the long-term survival from out-of-hospital cardiac arrest remains poor in most US cities. Paramount to achieving successful resuscitation of a cardiac arrest victim is providing early defibrillation. This issue of Cardiac Electrophysiology Clinics covers a full spectrum of issues related to sudden cardiac death, including the epidemiology of sudden cardiac death, advances in CPR, the implantable cardiac defibrillator (ICD), and VT ablation.

Atrial fibrillation is the most common sustained arrhythmia in humans. An incredible worldwide effort from physicians, scientists and industry over the last decade has brought forth new insights and therapeutic tools. We are fortunate to have achieved a level of understanding about this complex disease that we can indeed cure some patients. While we proceed at full speed ahead looking for cures for the rest, we have taken this opportunity in the Medical Clinics of North America to reflect on how much we have learned and on the task that lies ahead. This issue opens with a historical perspective, discusses many of the clinical issues in the management of atrial fibrillation, such as cardioversion, anticoagulation and ablation, and concludes with the current guidelines for treatment and a view of the future.

In collaboration with the Consulting Editors, Ranjan K. Thakur and Andrea Natale, Drs. Luigi Di Biase, Frank Marchlinski, and Andrea Natale have assembled an issue of Cardiac Electrophysiology Clinics on Advances in Atrial Fibrillation Ablation. Topics include, but are not limited to, Recurrent atrial fibrillation with isolated PVs, Beyond PVI in non paroxysmal atrial fibrillation, Recurrent atrial fibrillation after cryo, Recurrent atrial fibrillation after RF, high-density mapping, Expectation and Results of surrogate target beyond PVI, Lessons from epicardial mapping and ablation in refractory atrial fibrillation, Evolution of radiofrequency ablation parameters, Balloon based technologies, Energy sources, Current status of esophageal protection, Fluoroless atrial fibrillation ablation, Role of MRI imaging before and after ablation, When to stop OAC after atrial fibrillation ablation, Atrial fibrillation ablation trials, Risk Factor modification before and after atrial fibrillation ablation.

This issue of the Cardiology Clinics, edited by Ranjan K. Thakur, Andrea Natale, and Ziyad Hijazi, focuses on Cardioembolic Stroke. Topics covered in this issue include, but are not limited to: epidemiology of atrial fibrillation and stroke, atrial fibrillation and stroke, device detected atrial fibrillation, left atrial appendage closure for stroke prevention, cryptogenic strokes, and atrial fibrillation and cognitive decline.

Clinical cardiac electrophysiology is one of the most rapidly expanding fields in cardiology. There are currently no comprehensive case based books in this field. A Case Review of Cardiac Electrophysiology is a case based review of cardiac electrophysiology. The aim of this book is to provide a comprehensive case based review of cardiac electrophysiology. It will include implantable device cases as well as ablation cases and difficult clinical cases and may be used as a useful review in cardiac electrophysiology for those taking board examinations. There will also be cases that will be useful for associate professionals working in the field of cardiac electrophysiology including those individuals working for industry.